Mifepristone and the FDA’s exhaustive approval process, explained - podcast episode cover

Mifepristone and the FDA’s exhaustive approval process, explained

Apr 18, 202337 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

It’s been 10 days since a federal judge in Texas issued an unprecedented ruling that nullified the 2000 Food and Drug Administration approval of mifepristone, the first medication in a two-pill combination for medication abortion. A confusing legal battle ensued, and now we are waiting to hear from the Supreme Court. But we still want to know: What does this mean for the future of FDA drug approval? Vox’s Keren Landman (@landmanspeaking) explains.


References:

Abortion pill ruling: Why mifepristone is safe abortion medication - Vox 



Credits:

Jonquilyn Hill, host

Sofi LaLonde, producer

Cristian Ayala, engineer

A.M. Hall, editorial director of talk podcasts


Want to support The Weeds? Please consider making a donation to Vox: bit.ly/givepodcasts

Learn more about your ad choices. Visit podcastchoices.com/adchoices

For the best experience, listen in Metacast app for iOS or Android